Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 302 Carboplatin 155 Nivolumab 154 Cisplatin 139 Cyclophosphamide 130 Paclitaxel 127 Magnetic Resonance Spectroscopy 98 Specimen Handling 95 Radiotherapy 90 Gemcitabine 87 Dexamethasone 83 Biopsy 81 Ipilimumab 78 Docetaxel 75 Doxorubicin 75 Rituximab 69 Etoposide 67 atezolizumab 61 durvalumab 60 Lenalidomide 59 Radiation 59 Pemetrexed 58 Taxes 57 Bevacizumab 54 Prednisone 54 fludarabine 54 olaparib 53 Cytarabine 49 Vincristine 49 Fluorouracil 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × amrubicin × 1 year × Clear all

NCT05740566 2026-01-05

DeLLphi-304

Amgen

Phase 3 Active not recruiting

509 enrolled 11 charts 1 FDA

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡